X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospace.com/article/releases/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/
https://www.prnewswire.com/news-releases/clinical-trial-of-ganovo-and-ritonavir-combination-therapy-on-novel-coronavirus-pneumonia-301012147.html
https://www.biospectrumasia.com/news/28/14205/ascletis-opens-clinical-development-shanghai-center.html
https://endpts.com/roche-ties-up-again-with-ascletis-on-a-commercial-partnership-for-hep-b-drug/
https://endpts.com/on-its-way-to-making-hong-kong-history-ascletis-eyes-457m-haul-in-gic-backed-ipo/
https://www.prnewswire.com/news-releases/ascletis-receives-nda-approval-from-china-fda-for-ganovo-300665153.html
https://www.fiercepharma.com/pharma-asia/gilead-wins-chinese-approval-for-epclusa-but-emerging-market-getting-crowded
https://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cowen-38th-annual-healthcare-conference-300608207.html
https://www.fiercepharma.com/marketing/opdivo-repatha-and-lynparza-likely-among-china-s-2018-blockbuster-nods-report
Market Place
Share 
